Login to Your Account

AIDS 2012 Vaccine

Analysis Adds to Understanding of RV144 Vaccine Trial Results

By Anette Breindl
Science Editor

Thursday, September 13, 2012
Novel analyses of the RV144 HIV vaccine trial, also known as the Thai trial, have analyzed viral variants that were able to get past the protection the vaccine offered. Those results, published in Nature and presented at the AIDS Vaccine 2012 conference this week, add to the emerging understanding that targeting certain parts of HIV's envelope protein is likely the best path to an effective vaccine.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription